Grants per year
Search results
-
Active
STUDY: COG ANBL1531 - JUBILANT DRAXIMAGE Inc. Protocol ANBL1531: A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Reichek, J. L. (PD/PI)
Children’s Hospital of Philadelphia, Children’s Oncology Group
6/5/20 → 8/31/50
Project: Research project